EDITORIAL
Published on 07 Mar 2024
Editorial: New progress in cancer biomarkers and therapy
doi 10.3389/fmolb.2024.1388872
- 1,440 views
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- New Progress in Cancer Biomarkers and Therapy
New Progress in Cancer Biomarkers and Therapy
10k
Total downloads
44k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 29 Jan 2024
Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1
doi 10.3389/fonc.2024.1243432
- 1,057 views
- 2 citations
REVIEW
Published on 22 Dec 2023
Progress of non-small-cell lung cancer with ROS1 rearrangement
doi 10.3389/fmolb.2023.1238093
- 7,009 views
- 9 citations
ORIGINAL RESEARCH
Published on 11 Dec 2023
A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia
doi 10.3389/fmolb.2023.1281141
- 2,339 views
- 3 citations
ORIGINAL RESEARCH
Published on 28 Nov 2023
Mendelian randomization analysis to elucidate the causal relationship between small molecule metabolites and ovarian cancer risk
doi 10.3389/fonc.2023.1291033
- 2,168 views
- 1 citation
MINI REVIEW
Published on 09 Nov 2023
Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers
doi 10.3389/fmolb.2023.1289650
- 3,817 views
- 2 citations
ORIGINAL RESEARCH
Published on 05 Oct 2023
UroVysion™ fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
doi 10.3389/fmolb.2023.1250442
- 2,436 views
ORIGINAL RESEARCH
Published on 29 Aug 2023
Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma
doi 10.3389/fmolb.2023.1185832
- 1,659 views
- 4 citations
ORIGINAL RESEARCH
Published on 21 Aug 2023
Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
doi 10.3389/fmolb.2023.1232875
- 1,539 views
ORIGINAL RESEARCH
Published on 07 Jul 2023
Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
doi 10.3389/fmolb.2023.1198557
- 3,139 views
- 2 citations
ORIGINAL RESEARCH
Published on 04 Jul 2023
Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy
doi 10.3389/fmolb.2023.1184708
- 3,038 views
- 4 citations
ORIGINAL RESEARCH
Published on 20 Jun 2023
Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer
doi 10.3389/fmolb.2023.1208132
- 4,239 views
- 7 citations
